86 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
28 May 24
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
7:17am
in patients with Gorlin syndrome that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate
424B3
SLGL
Sol-Gel Technologies Ltd
20 May 24
Prospectus supplement
4:05pm
inhibitor to prevent the new basal cell carcinoma (BCC) lesions in patients with Gorlin syndrome that is expected to have an improved safety profile … an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation for the treatment of rare hyper
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
20 May 24
Sol-Gel Reports First Quarter 2024 Financial Results and Provides
7:15am
an improved safety profile compared to oral hedgehog inhibitors. Sol-Gel is conducting a Phase 3 clinical trial to investigate SGT-610 in approximately 140 … that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
to prevent the new basal cell carcinoma lesions in patients with Gorlin syndrome that is expected to have an improved safety profile compared to oral
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
1 Apr 24
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to
7:15am
that is expected to have an improved safety profile compared to oral hedgehog inhibitors as well as topical drug candidate SGT-210 under investigation
6-K
EX-99.1
mcjp8czfg7f 5t124oi
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
6-K
EX-99.1
o2y5nbpm1h4887eb po
30 Nov 23
Current report (foreign)
7:10am
424B3
a5lvqyen378v64e
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
t1j2p
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am
6-K
EX-99.1
yvn2ijgq
21 Nov 22
Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
4:42pm
6-K
EX-99.1
v9yzwk61bg0upn5pntb
4 Aug 22
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:32am
6-K
EX-99.1
66l1kw5bkrz n8
8 Jun 22
Current report (foreign)
7:15am
6-K
EX-99.1
q0xwc ayovh
16 May 22
Current report (foreign)
7:35am
6-K
EX-99.1
piq56x 03x6
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
424B5
vo97ubb21 5fbzew
19 Apr 22
Prospectus supplement for primary offering
4:02pm
20-F/A
ornpz1p8
7 Apr 22
Annual report (foreign) (amended)
4:06pm